Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion

Clinical Hemorheology and Microcirculation

Volumn 39, Issue 1-4, 2008, Pages 329-332

  Schenk, J F ^a   Stephan, B ^a   Zewinger, S ^a   Speer, T ^a   Pindur, G ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Abortion; Genetic plasminogen activator inhibitor 1 4G 5G polymorphism; Pregnancy; Venous thromboembolism

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PATHOGENESIS; PREGNANT WOMAN; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; ALLELES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 47849119554     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2008-1098     Document Type: Conference Paper

References (20)

1. E. Agapitos, C. Papadopouou, N. Kavantzas, J. Papoulias, V. Anatonaki and P. Davaris, The contribution of pathological examination of the placenta in the investigation of the causes of foetal mortality, Arch. Anat. Cytol. Pathol. 44 (1996), 5-11.
2. A. Alonso, I. Soto, M.F. Urgelles, J.R. Corte, M.J. Rodriguez and C.R. Pinto, Acquired and inherited thrombophilia in women with unexplained fetal loss, Am. J. Obstet. Gynecol. 187 (2002), 1337-1342.
3. G. Balta, C. Altay and A. Gurgey, PAI-1 gene 4G/5G genotype: A risk factor for thrombosis in vessels of internal organs, Am. J. Hematol. 71 (2002), 89-93.
4. C. Boettiger, W. Koch, C. Lahn, J. Mehilli, N. von Beckerath, A. Schoemig and A. Kastrati, 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting, Am. Heart J. 146 (2003), 855-861.
5. T. Buchholz, P. Lohse, N. Rogenhofer, E. Kosian, R. Pihusch and C.J. Thaler, Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages, Hum. Reprod. 18 (2003), 2473-2477.
6. C.B. Coulam, R.S. Jeyendran, L.A. Fishel and R. Roussev, Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage, Am. J. Reprod. Immunol. 55 (2006), 360-368.
7. G. Falk, H. Svensson, A. Almqvist and B. Wiman, Allele specific PCR for detection of sequence polymorphism in the promotor region of the plasminogen activator inhibitor-1 (PAI-1) gene, Fibrinolysis 9 (1995), 170-174.
8. A.R. Folsom, M. Cushman, S.R. Heckbert, W.D. Rosamond and N. Aleksie, Prospective study of fibrinolytic markers and venous thromboembolism, J. Clin. Epidemiol. 56 (2003), 598-603.
9. C.W. Francis, Plasminogen activator inhibitor-1 levels and polymorphisms, Arch. Pathol. Lab. Med. 126 (2002), 1401-1404.
10. C.J. Glueck, P. Wang, R.N. Fontaine, L. Sieve-Smith, T. Tracy and S.K. Moore, Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome, Metabolism 48 (1999), 1589-1595.
11. C.S. Goodman, C.B. Coulam, R.S. Jeyendran, V.A. Acosta and R. Roussev, Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss?, Am. J. Reprod. Immunol. 56 (2006), 230-236.
12. M.T. Sartori, B. Wiman, S. Vettore, F. Dazzi, A. Girolami and G.M. Patrassi, 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis, Thromb. Haemost. 80 (1998), 956-960.
13. M.T. Sartori, C. Danesin, G. Saggiorato, D. Tormene, P. Simioni, I. Spiezia, G.M. Patrassi and A. Girolami, The PAI-1 gene 4G/5G polymorphism and deep vein thrombosis in patients with inherited thrombophilia, Clin. Appl. Thromb. Hemost. 9 (2003), 299-307.
14. N.J. Sebire, M. Backos, S. El Gaddal, R.D. Goldin and L. Regan, Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients, Obstet. Gynecol. 101 (2003), 258-263.
15. R. Segui, A. Estelles, Y. Mira, F. Espana, P. Villa, C. Falco, A. Vaya, S. Grancha, F. Ferrando and J. Aznar, PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects, Br. J. Haematol. 111 (2000), 122-128.
16. A.S. Sotiriadis, A. Makrigiannakis, T. Stefos, E. Paraskevaidis and S.N. Kalantaridou, Fibrinolytic defects and recurrent miscarriage: a systematic review and meta-analysis, Obstet. Gynecol. 109 (2007), 1146-1155.
17. M. Stegnar, P. Uhrin, P. Peternel, A. Mavri, B. Salobir-Pajnic and J. Stare, The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism, Thromb. Haemost. 79 (1998), 975-979.
18. A.E. Tsantes, G.K. Nikolopoulos, P.G. Bagos, E. Rapti, G. Mantzios, V. Kapsimali and A. Travlou, Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis, Thromb. Haemost. 97 (2007), 907-913.
19. J.M. Visanji, J. Seargent, T. Tahri, S.A. Crift, M. Makris, F.E. Preston, I.R. Peake and M.E. Daly, Influence of the -675 4G/5G dimorphism of the plasminogen activator inhibitor 1 promoter on thrombotic risk in patients with factor V Leiden, Br. J. Haematol. 110 (2000), 135-138.
20. C.E. Wolf, H. Haubelt, H.U. Pauer, B. Hinney and C. Krome-Cesar, Recurrent pregnancy loss and its relation to FV Leiden, FII G20210A and polymorphisms of plasminogen activator and plasminogen activator inhibitor, Pathophysiol. Haemost. Thromb. 33 (2003), 134-137.